A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer

NIH RePORTER · NIH · U01 · $90,400 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract This application is for an administrative supplement to support our participation in the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreas Cancer (CPDPC). It will specifically enable the Stanford Clinical Center to continue its productive recruitment of patients into 3 key clinical studies of the consortium – 1) Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED), 2) Pediatric Longitudinal Cohort Study of Chronic Pancreatitis [The International Study Group of Pediatric Pancreatitis: In Search for a Cure (INSPPIRE2), and 3) Evaluation of a mixed meal test for Diagnosis and characterization of Pancreaticogenic Diabetes secondary to pancreatic cancer and chronic pancreatitis (DETECT). These funds will support patient related costs in enrollment and fulfilling protocol-defined tasks including the collection and processing of biospecimens for each protocol.

Key facts

NIH application ID
10252512
Project number
3U01DK108300-06S1
Recipient
STANFORD UNIVERSITY
Principal Investigator
Aida Habtezion
Activity code
U01
Funding institute
NIH
Fiscal year
2020
Award amount
$90,400
Award type
3
Project period
2020-09-05 → 2021-06-30